ReviewRSC advances2026
A review on the synthesis of β-TCP using different methods for biomedical applications.
Review in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Beta-tricalcium phosphate (β-TCP) is widely utilized in biomedical applications due to its outstanding biocompatibility and strong osteoconductive properties. Its high bioresorbability in the physiological environment allows the implanted material to undergo slow, controlled degradation over time, facilitating a gradual replacement with the body's native tissue, making it particularly suitable for bone reconstruction. A large number of studies have investigated the synthesis of β-TCP using a variety of chemical approaches, including both dry and wet approaches. Each method has distinct advantages and limitations, and these significantly influence crystallite size, crystallinity, densification behavior, shrinkage, morphology, and the overall properties of the final product. For surgical implants that require high mechanical strength, achieving high ceramic density is essential. The use of nano-sized β-TCP powders as starting materials has proven effective in producing dense ceramics. Furthermore, to preserve the resorbability of β-TCP, it is critical to obtain a pure phase. For these reasons, investigations into β-TCP synthesis have steadily increased, with a particular focus on tailoring its crystallographic properties. This review focuses on six methods for synthesizing β-TCP for bone grafting materials, dental implant applications, and bone tissue engineering. Traditional β-TCP synthesis is often criticized for generating large, non-uniform particles and secondary phases at high temperatures. In contrast, methods such as sol-gel, hydrothermal, solution combustion, and chemical precipitation are preferred for their superior control over the final product properties. We summarize the available information on each synthesis process, including benefits and drawbacks.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.